NHS England’s plan to eliminate Hepatitis C decisively backed by High Court
NHS England’s plan to eliminate Hepatitis C in England by 2025 is on track after all aspects of a High Court challenge by pharmaceutical company AbbVie were dismissed.
The NHS’s single largest medicines procurement, a deal worth almost £1 billion over five years, was launched in April last year but contract start dates had to be delayed by six months after legal action by AbbVie.
The High Court today handed down the judgment decisively backing NHS England’s plans to eliminate Hepatitis C.
In the ruling, the judge rejected all challenges brought by AbbVie against NHS England’s smart procurement for the supply of curative, direct acting antiviral treatments and industry backed projects to find and treat people with the virus as quickly as possible.
John Stewart, director of specialised commissioning at NHS England, said: “Court cases such as this are a waste of NHS resources and taxpayers’ money, in this case resulting in an unavoidable delay in our efforts to tackle the threat of Hepatitis C, which disproportionately affects some of the most vulnerable and marginalised people in society.
“We remain committed to driving best value to help eliminate Hepatitis C in England by 2025 or sooner, and with this court case behind us we can now get on with the job.”
Hepatitis C is a cancer-causing infectious disease, spread by contact with an infected person’s blood.
In recent years, Public Health England estimated that around 160,000 people are infected with Hepatitis C in England, although around half are unaware of their infection.
The disease, which can go undetected until the liver becomes damaged, can now be successfully cured in weeks using new oral tablets.
In 2015, NHS England established 22 Operational Delivery Networks (ODNs) to support treatment and testing efforts across the country and over 32,000 patients have been treated so far with around 95% being cured of the disease. NHS England plans to eliminate Hepatitis C in England by 2025, five years earlier than World Health Organisation goals.
The Hepatitis C procurement is the latest in a series of ‘smart deals’ the NHS has delivered to drive value for the taxpayer and benefits for patients.
These include a £300 million saving after negotiating deals with five manufacturers on low cost versions of the health service’s most costly drug, adalimumab; striking the first full access deal in Europe for CAR-T therapy which can potentially cure some children and adults with blood cancers where other treatments have failed; and reaching a deal to make the life-extending lung cancer drug pembrolizumab, available for routine use on the NHS.
Latest News from
Simon Stevens challenges ambulance makers to help ‘blue lights go green’15/02/2019 09:15:00
NHS chief Simon Stevens yesterday challenged vehicle manufacturers to help “blue lights go green” and cut air pollution by developing more environmentally friendly ambulances.
Barbara Windsor’s husband issues Valentine’s Day call for people to check loved ones for dementia14/02/2019 13:15:00
Scott Mitchell, the husband of acting legend Barbara Windsor, has today issued a Valentine’s Day call for people to heed NHS advice and check loved ones for signs of dementia.
Hospital admissions for youths assaulted with sharp objects up almost 60%12/02/2019 09:15:00
Teenagers accounted for more than 1,000 admissions to hospital as a result of assaults with a knife or sharp object last year, NHS figures show.
NHS to rollout lung cancer scanning trucks across the country08/02/2019 16:43:00
Lung cancer scanning trucks that operate from supermarket car parks are being rolled out across the country in a drive to save lives by catching the condition early, NHS England announced today.
Older patients spared dementia and falls by NHS tech roll-out08/02/2019 13:43:00
Digital checks that can prevent dementia and falls in older people, and save lives through diagnosis of sepsis, are among a range of tools being made available in hospitals across the country, as part of the NHS Long Term Plan.
Top doctor calls for ban on ‘damaging and misleading’ celebrity social media ads04/02/2019 12:05:00
England’s top doctor has called on social media companies to protect young and vulnerable users by banning irresponsible and unsafe celebrity endorsements.
GPs create 100,000 extra patient appointments through Primary Care Network model04/02/2019 10:10:00
GP practices in Gloucestershire are working together to provide 100,000 more appointments for patients.
Clinical pharmacists vital to patient care in five-year GP deal01/02/2019 14:15:00
Pharmacists will take on an expanded role at the heart of local primary care networks across the country, NHS England has confirmed.
Five-year deal to expand GP services and kick start NHS Long Term Plan implementation31/01/2019 13:15:00
A new five-year contract for general practice across England will see billions of extra investment for improved access to family doctors, expanded services at local practices and longer appointments for patients who need them.